The global Chimeric Antigen Receptor T-cell therapy market is experiencing rapid growth, driven by the growing prevalence of cancer, advancements in therapeutic approaches, and supportive regulatory scenerios. The market is segmented by indication, technology, and geography. Key players in the marke